What to expect in your first month on a GLP‑1 - a week-by-week guide

Introduction

Your first month on a GLP‑1 medication is when your body adjusts to a new way of regulating appetite and digestion. Whether you are starting semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), the initial weeks bring noticeable changes, some exciting and some uncomfortable. Knowing what is normal helps you stay on track and avoid unnecessary worry. This week-by-week guide covers what the clinical data and real-world experience tell us about the first 30 days.

Week one: the adjustment begins

Most patients begin on the lowest dose of their medication to minimize side effects. In the first few days after your injection, you may notice:

• Reduced appetite: Many people report a noticeable decrease in hunger within 24 to 48 hours of their first dose. Food may seem less appealing than usual, and portions that once felt normal may now feel too large.
• Mild nausea: Nausea is the most common early side effect, reported in 15.8 percent of patients at the Ozempic 0.5 mg starting dose. It tends to be mild and may feel like a vague queasiness rather than outright sickness.
• Changes in digestion: Your stomach is emptying more slowly than before. This may cause bloating, mild constipation, or a feeling of fullness after small amounts of food.

These effects are your body responding to the medication as intended. They do not mean something is wrong.

Week two: finding your rhythm

By the second week, the initial novelty wears off and you begin adjusting:

• Side effects may peak: For some patients, GI symptoms like nausea or bloating are at their worst during the first two weeks, then begin to fade.
• Eating patterns shift: You may find yourself naturally eating less without trying. Some people forget to eat because hunger signals are so much quieter than before.
• Hydration becomes important: With reduced food intake and slower digestion, dehydration is a real risk. Aim to drink water throughout the day, not just at meals.

This is an important week to establish tracking habits. What you record now creates a baseline for understanding how the medication affects you specifically.

Week three: early results appear

By week three, measurable changes are starting:

• Weight change: Most patients see their first measurable weight loss, typically 2 to 5 pounds in the first month. The rate varies based on starting weight, dose, activity level, and diet.
• Improved side effects: Many patients report that nausea and bloating are noticeably better by week three. The body is adapting to the medication’s effects on gastric motility.
• Mood and energy shifts: Some patients feel more energetic as appetite stabilizes. Others experience low energy from reduced calorie intake, especially if protein intake is too low.

Week four: preparing for what comes next

At the end of the first month, you are approaching your first dose adjustment:

• Titration ahead: Most GLP‑1 medications increase the dose after four weeks. Expect that some side effects, particularly nausea, may return temporarily after the dose increase, though they are usually milder than the first time.
• Patterns are emerging: By now, your body’s response pattern is becoming clearer. You likely know which days after injection are hardest, which foods sit well, and how your energy levels are shifting.
• Provider check-in: Many prescribers schedule a follow-up around the one-month mark. Having tracked data to share makes this conversation much more productive.

When to contact your provider

Most first-month symptoms are expected and resolve on their own. However, seek medical attention if you experience:

• Persistent vomiting that prevents you from keeping down food or fluids for more than 24 hours.
• Severe abdominal pain or tenderness, especially in the upper abdomen, which could indicate pancreatitis.
• Signs of dehydration: dark urine, dizziness, rapid heart rate, or inability to drink fluids.
• Severe diarrhea or constipation that does not improve with dietary adjustments.
• Allergic reaction symptoms: swelling, rash, or difficulty breathing at or after the injection site.

Start tracking from day one with Shotsy

Log your first dose in Shotsy, set up your weekly reminders, and use the side effect sliders to rate how you feel each day. By the end of month one, your calendar shows a clear picture of which side effects improved, how your weight changed, and how your appetite shifted. This data is invaluable for your first follow-up appointment.

Conclusion

Your first month on a GLP‑1 is an adjustment period, not a final verdict on how the medication will work for you. Reduced appetite, mild GI effects, and gradual weight loss are all expected. Side effects typically peak in the first two weeks and improve steadily after that. Track your experience from the start so you have real data for your next provider visit rather than relying on memory.